Epidermal RAF prevents allergic skin disease

Area of Science:

• Dermatology
• Molecular Biology
• Immunology

Background:

• The RAS pathway is crucial for skin homeostasis and keratinocyte proliferation.
• RAF kinases are therapeutic targets, but RAF inhibitors can paradoxically increase epidermal proliferation.
• Understanding RAF kinase function in keratinocytes is essential for treating skin disorders.

Purpose of the Study:

• To investigate the role of BRAF and RAF1 in epidermal homeostasis and skin disease.
• To explore the mechanisms by which RAF kinases regulate keratinocyte signaling.
• To develop a mouse model for atopic dermatitis.

Main Methods:

• Generated mice with conditional epidermis-restricted BRAF/RAF1 ablation.
• Analyzed skin barrier function, immune responses, and MAPK signaling pathways.
• Utilized JNK and MEK/ERK inhibitors to dissect pathway பங்க்ஷன்.

Main Results:

• Epidermal BRAF/RAF1 ablation induced a disease resembling human atopic dermatitis, with IgE responses and inflammation.
• BRAF promotes ERK activation, while RAF1 suppresses stress kinase activation, independently balancing MAPK signaling.
• JNK inhibition prevented disease onset; MEK/ERK inhibition in RAF1-deficient mice phenocopied the disease.

Conclusions:

• Keratinocytes play a central role in the pathogenesis of atopic dermatitis.
• BRAF and RAF1 have distinct, independent roles in regulating epidermal homeostasis.
• Mice lacking epidermal BRAF and RAF1 provide a valuable model for studying atopic dermatitis.